Clinical Trial Update: ATAC - Pharmacokinetics (PK) Sub-Protocol [Phase 3]

View source ↗

Summary

Phase 3 pharmacokinetics sub-protocol update for the ATAC trial in breast cancer. The update centers on PK study design and procedures rather than efficacy or s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anastrozole (Anastrozole)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED